Osteoclast biology in bone resorption: a review
What we know about bone resorption has changed a lot in the last few decades. The osteoclast is the only cell to nibble and break down the bone, and in the formation and resorption of bone tissue, osteoclasts play an important role. Once the balance of bone formation and bone loss is out of control,...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Innovation Publishing House Pte. Ltd.
2020-09-01
|
| Series: | STEMedicine |
| Subjects: | |
| Online Access: | https://stemedicine.org/index.php/stem/article/view/57 |
| _version_ | 1811281553310875648 |
|---|---|
| author | Chao Fu Ruyi Shi |
| author_facet | Chao Fu Ruyi Shi |
| author_sort | Chao Fu |
| collection | DOAJ |
| description | What we know about bone resorption has changed a lot in the last few decades. The osteoclast is the only cell to nibble and break down the bone, and in the formation and resorption of bone tissue, osteoclasts play an important role. Once the balance of bone formation and bone loss is out of control, diseases like osteopetrosis and osteoporosis occur. Bone resorption is a unique function of osteoblasts, which are multinucleated cells formed by the fusion of mononuclear progenitor cells of the monocyte/macrophage family. In the formation of osteoclasts, there are two main factors affecting this process, macrophage colony-stimulating factor (M-CSF) and ligand-activated receptor (RANKL) of nuclear factor kappa B (NF-κB). The identification of RANK-RANKL signaling and other classic signaling pathways such as Wnt and Notch, as the major signaling regulation in osteoclast differentiation, was a significant breakthrough in the field of osteoclastogenesis. In this review, we briefly describe the latest knowledge of osteoclast-induced bone resorption and cellular factors that regulate the activity of osteoclasts and cell fusion, for the purpose of understanding osteoclastogenesis and the development of drugs that enhance bone resorption to improve pathological bone diseases. |
| first_indexed | 2024-04-13T01:35:39Z |
| format | Article |
| id | doaj.art-bce3d52890af4969a0c4d7d5d7a67b7f |
| institution | Directory Open Access Journal |
| issn | 2705-1188 |
| language | English |
| last_indexed | 2024-04-13T01:35:39Z |
| publishDate | 2020-09-01 |
| publisher | Innovation Publishing House Pte. Ltd. |
| record_format | Article |
| series | STEMedicine |
| spelling | doaj.art-bce3d52890af4969a0c4d7d5d7a67b7f2022-12-22T03:08:22ZengInnovation Publishing House Pte. Ltd.STEMedicine2705-11882020-09-011410.37175/stemedicine.v1i4.57Osteoclast biology in bone resorption: a reviewChao Fu0Ruyi Shi1College of Fundamental Medicine, Shanxi Medical University, Taiyuan, Shanxi 030001, ChinaKey Laboratory of Cellular Physiology, Chinese Ministry of Education; Department of Cell Biology and Genetics, Shanxi Medical University, Taiyuan, Shanxi 030001, ChinaWhat we know about bone resorption has changed a lot in the last few decades. The osteoclast is the only cell to nibble and break down the bone, and in the formation and resorption of bone tissue, osteoclasts play an important role. Once the balance of bone formation and bone loss is out of control, diseases like osteopetrosis and osteoporosis occur. Bone resorption is a unique function of osteoblasts, which are multinucleated cells formed by the fusion of mononuclear progenitor cells of the monocyte/macrophage family. In the formation of osteoclasts, there are two main factors affecting this process, macrophage colony-stimulating factor (M-CSF) and ligand-activated receptor (RANKL) of nuclear factor kappa B (NF-κB). The identification of RANK-RANKL signaling and other classic signaling pathways such as Wnt and Notch, as the major signaling regulation in osteoclast differentiation, was a significant breakthrough in the field of osteoclastogenesis. In this review, we briefly describe the latest knowledge of osteoclast-induced bone resorption and cellular factors that regulate the activity of osteoclasts and cell fusion, for the purpose of understanding osteoclastogenesis and the development of drugs that enhance bone resorption to improve pathological bone diseases.https://stemedicine.org/index.php/stem/article/view/57OsteoclastBone resorptionM-CSFRANKL pathwayCell fusion |
| spellingShingle | Chao Fu Ruyi Shi Osteoclast biology in bone resorption: a review STEMedicine Osteoclast Bone resorption M-CSF RANKL pathway Cell fusion |
| title | Osteoclast biology in bone resorption: a review |
| title_full | Osteoclast biology in bone resorption: a review |
| title_fullStr | Osteoclast biology in bone resorption: a review |
| title_full_unstemmed | Osteoclast biology in bone resorption: a review |
| title_short | Osteoclast biology in bone resorption: a review |
| title_sort | osteoclast biology in bone resorption a review |
| topic | Osteoclast Bone resorption M-CSF RANKL pathway Cell fusion |
| url | https://stemedicine.org/index.php/stem/article/view/57 |
| work_keys_str_mv | AT chaofu osteoclastbiologyinboneresorptionareview AT ruyishi osteoclastbiologyinboneresorptionareview |